BrainChild Bio, the Seattle Children's spinout developing CAR-T therapies for pediatric brain tumors, has secured 31,000 square feet at Alexandria Real Estate Equities'...
ByThe RegistryNovember 13, 2026
Signup for news and special announcements!
You have successfully joined our subscriber list.